Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Oct 21, 2021

SELL
$221.91 - $258.6 $242,325 - $282,391
-1,092 Closed
0 $0
Q4 2020

Oct 21, 2021

BUY
$216.38 - $257.67 $236,286 - $281,375
1,092 New
1,092 $246,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Blooom, Inc. Portfolio

Follow Blooom, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blooom, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Blooom, Inc. with notifications on news.